Concepts (95)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Renal Insufficiency, Chronic | 5 | 2023 | 837 | 1.340 |
Why?
|
| Sodium Bicarbonate | 2 | 2022 | 55 | 1.330 |
Why?
|
| Hepatitis C | 3 | 2023 | 390 | 1.230 |
Why?
|
| Hepatitis C, Chronic | 2 | 2023 | 367 | 1.050 |
Why?
|
| Kidney Transplantation | 4 | 2023 | 572 | 0.770 |
Why?
|
| Hypokalemia | 1 | 2022 | 40 | 0.720 |
Why?
|
| Renal Insufficiency | 2 | 2022 | 250 | 0.710 |
Why?
|
| Dog Diseases | 1 | 2022 | 58 | 0.700 |
Why?
|
| Accountable Care Organizations | 1 | 2020 | 7 | 0.670 |
Why?
|
| Water-Electrolyte Imbalance | 1 | 2020 | 77 | 0.590 |
Why?
|
| Graft Survival | 3 | 2023 | 465 | 0.580 |
Why?
|
| Sodium | 1 | 2020 | 281 | 0.580 |
Why?
|
| Anemia, Iron-Deficiency | 1 | 2021 | 139 | 0.570 |
Why?
|
| Kidney Failure, Chronic | 3 | 2021 | 942 | 0.520 |
Why?
|
| Cardiovascular Diseases | 2 | 2021 | 2081 | 0.510 |
Why?
|
| Peritoneal Dialysis | 1 | 2018 | 131 | 0.500 |
Why?
|
| Vitamin D | 1 | 2018 | 194 | 0.490 |
Why?
|
| Cause of Death | 1 | 2018 | 510 | 0.490 |
Why?
|
| Hospitalization | 1 | 2021 | 1939 | 0.360 |
Why?
|
| Hepacivirus | 3 | 2023 | 273 | 0.350 |
Why?
|
| Hypertonic Solutions | 2 | 2022 | 20 | 0.350 |
Why?
|
| Dogs | 2 | 2022 | 621 | 0.320 |
Why?
|
| Infusions, Intravenous | 2 | 2022 | 547 | 0.310 |
Why?
|
| Kidney | 4 | 2023 | 1304 | 0.290 |
Why?
|
| Transplant Recipients | 2 | 2022 | 234 | 0.280 |
Why?
|
| Renal Dialysis | 3 | 2020 | 951 | 0.280 |
Why?
|
| Health Expenditures | 2 | 2020 | 134 | 0.270 |
Why?
|
| Medicare | 2 | 2020 | 435 | 0.240 |
Why?
|
| Antiviral Agents | 2 | 2023 | 812 | 0.240 |
Why?
|
| United States | 6 | 2022 | 11794 | 0.190 |
Why?
|
| Antilymphocyte Serum | 1 | 2022 | 44 | 0.190 |
Why?
|
| Registries | 2 | 2020 | 1599 | 0.180 |
Why?
|
| Nephritis, Interstitial | 1 | 2022 | 40 | 0.180 |
Why?
|
| Glomerular Filtration Rate | 2 | 2022 | 564 | 0.170 |
Why?
|
| Potassium | 1 | 2022 | 270 | 0.170 |
Why?
|
| Acidosis | 1 | 2022 | 99 | 0.170 |
Why?
|
| Cost Savings | 1 | 2020 | 78 | 0.160 |
Why?
|
| Ferritins | 1 | 2021 | 109 | 0.160 |
Why?
|
| Cations, Monovalent | 1 | 2020 | 1 | 0.160 |
Why?
|
| Renal Elimination | 1 | 2020 | 11 | 0.160 |
Why?
|
| Hemodialysis Units, Hospital | 1 | 2020 | 9 | 0.160 |
Why?
|
| Health Facility Closure | 1 | 2020 | 8 | 0.160 |
Why?
|
| Prospective Payment System | 1 | 2020 | 16 | 0.160 |
Why?
|
| Humans | 13 | 2023 | 131501 | 0.150 |
Why?
|
| Tissue Distribution | 1 | 2020 | 366 | 0.150 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2020 | 426 | 0.150 |
Why?
|
| Specialization | 1 | 2019 | 75 | 0.150 |
Why?
|
| Waiting Lists | 1 | 2021 | 242 | 0.150 |
Why?
|
| Perioperative Care | 1 | 2021 | 215 | 0.140 |
Why?
|
| Health Policy | 1 | 2021 | 227 | 0.140 |
Why?
|
| Aged, 80 and over | 2 | 2021 | 6916 | 0.140 |
Why?
|
| Tissue and Organ Procurement | 1 | 2021 | 253 | 0.130 |
Why?
|
| Odds Ratio | 1 | 2021 | 1235 | 0.130 |
Why?
|
| Survival Rate | 1 | 2021 | 2149 | 0.120 |
Why?
|
| Graft Rejection | 3 | 2023 | 560 | 0.110 |
Why?
|
| Diabetes Mellitus | 1 | 2022 | 886 | 0.100 |
Why?
|
| Prevalence | 1 | 2021 | 2692 | 0.100 |
Why?
|
| Animals | 4 | 2022 | 34335 | 0.100 |
Why?
|
| Cohort Studies | 2 | 2022 | 5120 | 0.100 |
Why?
|
| Physicians | 1 | 2019 | 634 | 0.100 |
Why?
|
| Aged | 3 | 2021 | 21238 | 0.100 |
Why?
|
| Female | 6 | 2022 | 71086 | 0.090 |
Why?
|
| Texas | 1 | 2021 | 3614 | 0.090 |
Why?
|
| Adult | 4 | 2022 | 31666 | 0.090 |
Why?
|
| Prognosis | 1 | 2021 | 4951 | 0.090 |
Why?
|
| Middle Aged | 3 | 2021 | 28839 | 0.080 |
Why?
|
| Disease Models, Animal | 1 | 2020 | 4683 | 0.070 |
Why?
|
| Male | 5 | 2022 | 65158 | 0.070 |
Why?
|
| Time Factors | 1 | 2018 | 6273 | 0.070 |
Why?
|
| Young Adult | 2 | 2022 | 10092 | 0.070 |
Why?
|
| Adolescent | 2 | 2022 | 20918 | 0.050 |
Why?
|
| Histocompatibility Testing | 1 | 2023 | 109 | 0.050 |
Why?
|
| Agrochemicals | 1 | 2022 | 13 | 0.050 |
Why?
|
| Paraquat | 1 | 2022 | 15 | 0.050 |
Why?
|
| Cations | 1 | 2022 | 37 | 0.050 |
Why?
|
| Living Donors | 1 | 2023 | 115 | 0.050 |
Why?
|
| HLA Antigens | 1 | 2023 | 229 | 0.040 |
Why?
|
| Rabbits | 1 | 2022 | 633 | 0.040 |
Why?
|
| Health Care Rationing | 1 | 2021 | 59 | 0.040 |
Why?
|
| Europe | 1 | 2021 | 372 | 0.040 |
Why?
|
| Health Care Reform | 1 | 2020 | 52 | 0.040 |
Why?
|
| Tissue Donors | 1 | 2023 | 502 | 0.040 |
Why?
|
| Immunosuppressive Agents | 1 | 2022 | 667 | 0.040 |
Why?
|
| Antibodies, Monoclonal | 1 | 2022 | 1008 | 0.030 |
Why?
|
| Health Care Costs | 1 | 2020 | 400 | 0.030 |
Why?
|
| Practice Guidelines as Topic | 1 | 2022 | 1305 | 0.030 |
Why?
|
| Chronic Disease | 1 | 2019 | 1233 | 0.030 |
Why?
|
| Health Services Accessibility | 1 | 2021 | 695 | 0.030 |
Why?
|
| Pandemics | 1 | 2021 | 1160 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2022 | 3834 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2022 | 4762 | 0.020 |
Why?
|
| Retrospective Studies | 2 | 2022 | 17648 | 0.020 |
Why?
|
| Risk Factors | 1 | 2022 | 10952 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2022 | 12937 | 0.010 |
Why?
|
| Mice | 1 | 2022 | 18470 | 0.010 |
Why?
|